keyword
https://read.qxmd.com/read/38689429/wnt5b-drives-osteosarcoma-stemness-chemoresistance-and-metastasis
#1
JOURNAL ARTICLE
Rachel S Perkins, Glenn Murray, Sarocha Suthon, Lindsey Davis, Nicholson B Perkins, Lily Fletcher, Amanda Bozzi, Saylor L Schreiber, Jianjian Lin, Steven Laxton, Rahul R Pillai, Alec J Wright, Gustavo A Miranda-Carboni, Susan A Krum
BACKGROUND: Treatment for osteosarcoma, a paediatric bone cancer with no therapeutic advances in over three decades, is limited by a lack of targeted therapies. Osteosarcoma frequently metastasises to the lungs, and only 20% of patients survive 5 years after the diagnosis of metastatic disease. We found that WNT5B is the most abundant WNT expressed in osteosarcoma tumours and its expression correlates with metastasis, histologic subtype and reduced survival. METHODS: Using tumor-spheroids to model cancer stem-like cells, we performed qPCR, immunoblotting, and immunofluorescence to monitor changes in gene and protein expression...
May 2024: Clinical and Translational Medicine
https://read.qxmd.com/read/38689362/pembrolizumab-response-in-stage-iv-luminal-type-breast-cancer-with-high-microsatellite-instability-a-case-report
#2
JOURNAL ARTICLE
Keiko Inakami, Noriko Fujita, Chikage Iguchi, Yukie Enomoto, Junya Minohata, Atsushi Sata, Yoshimasa Miyagawa, Tetsu Yanagisawa, Tomokazu Saitoh, Takashi Nomura, Yuka Sawai, Keiko Takahara, Tsutomu Kasugai, Eiichi Shiba
BACKGROUND: Pembrolizumab (PEM), an immune checkpoint inhibitor (ICI), is often used for triple-negative breast cancer, but can also be used to treat solid tumors that exhibit high microsatellite instability (MSI-High). However, patients with breast cancer rarely have MSI-High, the use of PEM in such cases in clinical practice is uncertain due to lack of sufficient supporting data. Here, we report the case of a premenopausal woman in who received PEM for MSI-High luminal-type breast cancer...
May 1, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38689334/loss-of-tumor-derived-smad4-enhances-primary-tumor-growth-but-not-metastasis-following-bmp4-signalling
#3
JOURNAL ARTICLE
Lap Hing Chi, Andrew D Redfern, Suraya Roslan, Ian P Street, Allan D Burrows, Robin L Anderson
BACKGROUND: Bone morphogenetic protein 4 (BMP4) is a potent inhibitor of breast cancer metastasis. However, a tumor-promoting effect of BMP4 is reported in other tumor types, especially when SMAD4 is inactive. METHODS: To assess the requirement for SMAD4 in BMP4-mediated suppression of metastasis, we knocked down SMAD4 in two different breast tumors and enforced SMAD4 expression in a third line with endogenous SMAD4 deletion. In addition, we assessed the requirement for SMAD4 in tumor cell-specific BMP signalling by expression of a constitutively active BMP receptor...
April 30, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38688644/acute-myelomonoblastic-leukemia-my1-de-a-preclinical-rat-model
#4
JOURNAL ARTICLE
Viktória Arató, Zita Képes, Judit P Szabó, Gergely Farkasinszky, Tamás Sass, Noémi Dénes, Adrienn Kis, Gábor Opposits, István Jószai, Ferenc Krisztián Kálmán, István Hajdu, György Trencsényi, István Kertész
BACKGROUND/AIM: Since acute myeloid leukemias still represent the most aggressive type of adult acute leukemias, the profound understanding of disease pathology is of paramount importance for diagnostic and therapeutic purposes. Hence, this study aimed to explore the real-time disease fate with the establishment of an experimental myelomonoblastic leukemia (My1/De) rat model using preclinical positron emission tomography (PET) and whole-body autoradiography. MATERIALS AND METHODS: In vitro [18 F]F-FDG uptake studies were performed to compare the tracer accumulation in the newly cultured My1/De tumor cell line (blasts) with that in healthy control and My1/De bone marrow suspensions...
2024: In Vivo
https://read.qxmd.com/read/38687345/merkel-cell-carcinoma-metastases-to-caruncle-with-orbital-extension-report-and-literature-review
#5
JOURNAL ARTICLE
Josefina Herrera, Krishna Tumuluri
Merkel cell carcinoma (MCC) is an uncommon and aggressive skin cancer of neuroendocrine origin. The tumor usually presents with a locoregional spread and most frequently metastasizes to the skin, liver, bone, lung, and brain. Despite the orbit being a relatively common site of metastases, it has rarely been reported in patients with MCC. The authors present a case of biopsy-proven orbital metastatic MCC in an 86-year-old male who presented with a rapidly enlarging right caruncle/subconjunctival mass with orbital extension and a history of forearm MCC excision 3 years prior...
April 29, 2024: Ophthalmic Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38686487/comparison-of-68ga-fapi-04-pet-ct-with-18f-fdg-pet-ct-for-diagnosis-and-staging-of-gastric-and-colorectal-cancer
#6
JOURNAL ARTICLE
Bin Wang, Xinming Zhao, Yunuan Liu, Zhaoqi Zhang, Xiaoshan Chen, Fenglian Jing, Xiaolin Chen, Yu Hua, Jianqiang Zhao
OBJECTIVE: The objective of this study is to evaluate the effectiveness of 68Ga-FAPI-04 PET/computed tomography (CT) for the diagnosis of primary and metastatic gastric cancer and colorectal cancer lesions as compared with 18F-FDG PET/CT. MATERIALS AND METHODS: Fifty-nine patients who underwent both 18F-FDG and 68Ga-FAPI-04 for initial staging or restaging were enrolled. Histopathological findings and clinical imaging follow-up were used as the reference standard...
April 29, 2024: Nuclear Medicine Communications
https://read.qxmd.com/read/38686071/lethal-disseminated-intravascular-coagulation-induced-by-primary-and-metastatic-neuroendocrine-prostate-cancer
#7
Takashi Ando, Taro Sasaki, Makoto Naito
INTRODUCTION: Neuroendocrine prostate cancer has a poor prognosis. Although disseminated intravascular coagulation associated with malignancy can be lethal, it very rarely occurs among patients with primary neuroendocrine prostate cancer. CASE PRESENTATION: An 80-year-old man presented to our hospital with bloody sputum. Blood examination indicated disseminated intravascular coagulation. Serum levels of prostate-specific antigen and neuron-specific enolase were 44...
May 2024: IJU case reports
https://read.qxmd.com/read/38680059/albumin-binding-lutetium-177-labeled-llp2a-derivatives-as-theranostics-for-melanoma
#8
JOURNAL ARTICLE
Michael D Pun, Fabio Gallazzi, Khanh-Van Ho, Lisa Watkinson, Terry L Carmack, Ejike Iweha, Longbo Li, Carolyn J Anderson
Very late antigen-4 (VLA-4) is a transmembrane integrin protein that is highly expressed in aggressive forms of metastatic melanoma. A small-molecule peptidomimetic, LLP2A, was found to have a low pM affinity binding to VLA-4. Because LLP2A itself does not inhibit cancer cell proliferation and survival, it is an ideal candidate for the imaging and delivery of therapeutic payloads. An analog of [177 Lu]Lu-labeled-LLP2A was previously investigated as a therapeutic agent in melanoma tumor-bearing mice, resulting in only a modest improvement in tumor growth inhibition, likely due to rapid clearance of the agent from the tumor...
April 29, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38672596/assessment-of-psma-expression-of-healthy-organs-in-different-stages-of-prostate-cancer-using-68-ga-ga-psma-11-pet-examinations
#9
JOURNAL ARTICLE
Holger Einspieler, Kilian Kluge, David Haberl, Katrin Schatz, Lukas Nics, Stefan Schmitl, Barbara Katharina Geist, Clemens P Spielvogel, Bernhard Grubmüller, Pascal A T Baltzer, Gero Kramer, Shahrokh F Shariat, Marcus Hacker, Sazan Rasul
The efficacy of radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) is currently being investigated for its application in patients with early-stage prostate cancer (PCa). However, little is known about PSMA expression in healthy organs in this cohort. Collectively, 202 [68 Ga]Ga-PSMA-11 positron emission tomography (PET) scans from 152 patients were studied. Of these, 102 PET scans were from patients with primary PCa and hormone-sensitive biochemically recurrent PCa and 50 PET scans were from patients with metastatic castration-resistant PCa (mCRPC) before and after three cycles of [177 Lu]Lu-PSMA-RLT...
April 16, 2024: Cancers
https://read.qxmd.com/read/38670263/efficacy-of-metastatic-lesion-radiotherapy-in-patients-with-metastatic-nasopharyngeal-carcinoma-a-multicenter-retrospective-study
#10
JOURNAL ARTICLE
Yang Liu, Jie Ma, Xiao-Yi Zeng, Zhi-Chao Zuo, Rui-Zhong Chen, Xiao-Yu Li, Zhong-Guo Liang, Kai-Hua Chen, Xin-Bin Pan, Su Pei, Bin-Bin Yu, Ling Li, Song Qu, Yun-Li Yang, Xiao-Dong Zhu
OBJECTIVE: We investigated the efficacy of metastatic lesion radiotherapy (MLRT) in patients with metastatic nasopharyngeal carcinoma (mNPC). MATERIALS AND METHODS: Patients with mNPC from three institutions were included in this study. Propensity score matching (PSM) was employed to ensure comparability between patient groups. Overall survival (OS) rates were assessed using the Kaplan-Meier method and compared using the log-rank test. Prognostic factors were identified using univariate and multivariate Cox hazard analyses...
April 24, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38668060/current-concepts-in-the-treatment-of-giant-cell-tumor-of-bone-an-update
#11
REVIEW
Shinji Tsukamoto, Andreas F Mavrogenis, Tomoya Masunaga, Kanya Honoki, Hiromasa Fujii, Akira Kido, Yasuhito Tanaka, Costantino Errani
Curettage is recommended for the treatment of Campanacci stages 1-2 giant cell tumor of bone (GCTB) in the extremities, pelvis, sacrum, and spine, without preoperative denosumab treatment. In the distal femur, bone chips and plate fixation are utilized to reduce damage to the subchondral bone and prevent pathological fracture, respectively. For local recurrence, re-curettage may be utilized when feasible. En bloc resection is an option for very aggressive Campanacci stage 3 GCTB in the extremities, pelvis, sacrum, and spine, combined with 1-3 doses of preoperative denosumab treatment...
April 8, 2024: Current Oncology
https://read.qxmd.com/read/38667451/aortic-angiosarcoma-manifesting-as-multiple-musculoskeletal-metastases-a-case-report
#12
JOURNAL ARTICLE
Won Jong Bahk, Sae Jung Na, In Yong Whang, Yongju Kim, Kyung Jin Seo
Aortic angiosarcomas are rare. Due to its rarity and metastatic presentation, it is difficult to diagnose metastatic aortic angiosarcoma. We describe the clinicopathological and radiologic features of a metastatic aortic angiosarcoma presenting as musculoskeletal metastases. A 59-year-old male patient presented with left thigh pain. Plain radiographs revealed multifocal osteolytic lesions in the left femur shaft. Abdominopelvic computed tomography showed a lobulated osteolytic lesion in the left iliac bone...
April 11, 2024: Diagnostics
https://read.qxmd.com/read/38660900/-analysis-of-41-cases-of-non-metastatic-ewing-s-sarcoma-in-children
#13
JOURNAL ARTICLE
Qing Yuan, Ya-Li Han, Ci Pan, Jing-Yan Tang, Yi-Jin Gao
OBJECTIVES: To summarize the clinical characteristics, treatment outcomes, and prognostic factors of children with non-metastatic Ewing's sarcoma (ES). METHODS: A retrospective analysis was conducted on the clinical data of 41 children with non-metastatic ES diagnosed and treated at the Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine from January 2010 to December 2018. All patients underwent chemotherapy based on the RMS-2009 protocol of the center, and local treatment such as surgery and/or radiotherapy was performed according to risk grouping...
April 15, 2024: Zhongguo Dang Dai Er Ke za Zhi, Chinese Journal of Contemporary Pediatrics
https://read.qxmd.com/read/38655687/prospective-pilot-study-utilizing-changes-in-quantitative-values-obtained-on-serial-fluorine-18-fluorodeoxyglucose-18-f-fdg-positron-emission-tomography-computed-tomography-pet-ct-in-dogs-with-appendicular-osteosarcoma-before-and-after-stereotactic-body-radiation
#14
JOURNAL ARTICLE
Tiffany W Martin, Lynn Griffin
Serial fluorine 18 fluorodeoxyglucose (18 F-FDG) positron emission tomography-CT (PET/CT) is commonly used in human oncology to prognosticate and evaluate for therapeutic effectiveness. In this pilot study, dogs with naturally occurring appendicular osteosarcoma were evaluated with serial 18 F-FDG PET/CT in an attempt to assess for response to therapy, prognostic factors, and appropriateness of imaging intervals. Fourteen dogs were enrolled in the trial. All dogs had the initial 18 F-FDG PET/CT (PET1), with nine dogs having their end-of-therapy 18 F-FDG PET/CT (EoT PET) 3 months after stereotactic body radiation therapy (SBRT) to the primary tumor...
April 24, 2024: Veterinary Radiology & Ultrasound
https://read.qxmd.com/read/38653170/ewing-sarcoma-with-intra-thoracic-and-multiple-extra-thoracic-metastases-in-a-young-adult-male-a-case-report
#15
Noni Novisari Soeroso, Nurul Ramadhani, Setia Putra Tarigan
INTRODUCTION: Primary chest wall tumors arise from muscle, fat, blood vessels, the nerve sheath, cartilage, or bone of the chest wall. One of the chest wall sarcomas is Ewing Sarcoma (ES), first described in 1921 by James Ewing, which is a highly aggressive bone and soft-tissue cancer. This case report aimed to present an Ewing Sarcoma with intra thoracic and multiple extra thoracic metastases in young adult male patient. PRESENTATION OF CASE: We describe a unique case of metastatic of ewing's sarcoma in a 23-year-old male that showed a mass on the right lower posterior lung with pleural effusion, which was initially thought to be lung tumor that metastasized to the pleura...
April 20, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38651154/case-report-salivary-duct-carcinoma-in-a-patient-with-a-germline-cdh1-pathogenic-variant-expanding-the-spectrum-of-hereditary-cancer-predisposition-syndromes
#16
Nidhi Desai, Emilian Racila, Naomi Fujioka, Arjun Gupta, Emmanuel S Antonarakis
INTRODUCTION: Recently, an entity known as salivary duct carcinoma with rhabdoid features (SDC-RF) has been associated with somatic CDH1 mutations. Here we present the first known case report of conventional SDC occurring in the setting of a germline CDH1 pathogenic variant accompanied by a somatic loss of heterozygosity at the CDH1 locus. CASE DISCUSSION: A 67-year-old man presented with chest and back pain and was found to have osteolytic lesions in the sternum and lumbar spine...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38649653/the-impact-of-non-bone-metastatic-cancer-on-musculoskeletal-health
#17
REVIEW
Fabiola Galiana-Melendez, Joshua R Huot
PURPOSE OF REVIEW: The purpose of this review is to discuss the musculoskeletal consequences of cancer, including those that occur in the absence of bone metastases. RECENT FINDINGS: Cancer patients frequently develop cachexia, a debilitating condition reflected by weight loss and skeletal muscle wasting. The negative effects that tumors exert on bone health represents a growing interest amongst cachexia researchers. Recent clinical and pre-clinical evidence demonstrates cancer-induced bone loss, even in the absence of skeletal metastases...
April 22, 2024: Current Osteoporosis Reports
https://read.qxmd.com/read/38646638/hypofractionated-radiotherapy-combined-with-lenalidomide-improves-systemic-antitumor-activity-in-mouse-solid-tumor-models
#18
JOURNAL ARTICLE
Kateryna Onyshchenko, Ren Luo, Xi Rao, Xuanwei Zhang, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann
Background: Hypofractionated radiotherapy (hRT) can induce a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade (ICB). However, clinically, this effect is still rare, and ICB-mediated adverse events are common. Lenalidomide (lena) is an anti-angiogenic and immunomodulatory drug used in the treatment of hematologic malignancies. We here investigated in solid tumor models whether lena can enhance the abscopal effect in double combination with hRT...
2024: Theranostics
https://read.qxmd.com/read/38646436/paratesticular-metastasis-from-colorectal-adenocarcinoma-presenting-as-hydrocele-a-rare-case-report-and-literature-review
#19
XiaoJun Huang, KeLi Xu, Yin Zhao, MinHui Chen, ZheYang Li
Colorectal cancer, with the liver being the most common site of distant metastasis, followed by the lungs and bones. Although reports of metastasis to the testis exist, paratesticular metastasis is extremely rare. A 37-year-old male presented with scrotal swelling. Ultrasound revealed hydrocele of the tunica vaginalis. The patient underwent routine surgical treatment, and postoperative pathology of the tunica vaginalis indicated adenocarcinoma of gastrointestinal origin. Colonoscopic biopsy confirmed adenocarcinoma of the sigmoid colon...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38646358/pediatric-prostatic-alveolar%C3%A2-rhabdomyosarcoma-presenting-with-metastatic-spinal-cord-compression-in-the-thoracic-spine-a-case-report-and-review-of-the-literature
#20
Matthew T Perry, Andrew J Witten, Majeed Marwan, Alexander Vortmeyer, Jignesh Tailor
Rhabdomyosarcoma (RMS) is a pediatric malignancy with a variable prognosis depending on tumor stage and genotype. There has been a significant improvement in survival rates over the past decades. However, aggressive variants can metastasize to locations that are difficult to treat. We report a case of prostatic alveolar rhabdomyosarcoma with metastases to the bone marrow and thoracic spine in a child. The patient was treated with a multimodal approach that included surgical resection of the epidural mass; the administration of vincristine, dactinomycin, and cyclophosphamide; and radiotherapy...
March 2024: Curēus
keyword
keyword
60732
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.